NIHCC13-010347

TITLE: DYNABEADS CD3/CD28 CTS 10ML

This is a notice of intent and not a request for competitive quotes. This acquisition is being conducted under simplified acquisition using FAR 12 procedures and is under FAR 6.302-1. The intended procurement will be classified under North American Industry Classification System Code 811219 with a size standard of 500 employees.

The National Institutes of Health, Clinical Center (CC) intends to award a fixed price purchase order to Life Technologies Corp., Grand Island, NY 14072 on a sole source basis to procure Dynabeads CD3/CD28 CTS (10ml).

Catalog Number Description Quantity
40203D Dynabeads CD3 35 vials
CD3/CD28 CTS
(10ml).

Life Technologies Corp is the sole manufacturer and trademark holder for the Dynabeads which are used for stimulation of cell in culture. Dynabeads are reagents used in the preparation of highly purified unique immunotherapy products for treatments of critically ill patients. A reagent is a substance used to detect or measure another substance or to convert one substance into another by means of the reaction which is causes. Patients are enrolled in approved clinical protocols. The Dynabeads are used for stimulation of cells in culture.

This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based on responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing to this posting number, may be submitted to the CC Office of Purchasing and Contracts, prior to the closing date specified in this announcement electronically to the attention of
Andre M. Moody, Contract Specialist, [email protected] by the due date and time marked on this notice.